GlassScriptPhysician profile
Pamela Bailey
NPI 1730509829
$1,684.00
in general payments reported to CMS, 2019-2025
7 companies · $233 in 2025
The $233 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $88.22 · 2021: $258 · 2022: $546 · 2023: $319 · 2024: $240 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $560.57 | 2022-2025 | Teflaro, Dalvance |
| Janssen Scientific Affairs, LLC | $363.84 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $203.51 | 2019-2023 | Recarbrio |
| Viiv Healthcare Company | $184.50 | 2021-2022 | |
| Gilead Sciences, INC. | $183.86 | 2021-2024 | |
| Glaxosmithkline, LLC. | $124.99 | 2024 | Shingrix |
| Ferring Pharmaceuticals INC. | $62.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.